Together with prior behavioral evidence, this study establishes the Shank3<sup>Δe11-21</sup> rat as a preclinical model for elucidating mechanisms of Shank3-related neurodevelopmental disorders and for evaluating potential early-life therapeutic interventions, including sleep-targeted strategies. This evidence concerns the gene SHANK3 and neurodevelopmental disorder.